loading
Precedente Chiudi:
$2.92
Aprire:
$2.87
Volume 24 ore:
874.41K
Relative Volume:
2.78
Capitalizzazione di mercato:
$161.99M
Reddito:
$44.12M
Utile/perdita netta:
$-156.25M
Rapporto P/E:
-0.7603
EPS:
-4.13
Flusso di cassa netto:
$-154.61M
1 W Prestazione:
-3.98%
1M Prestazione:
+0.96%
6M Prestazione:
-16.49%
1 anno Prestazione:
-7.10%
Intervallo 1D:
Value
$2.87
$3.19
Intervallo di 1 settimana:
Value
$2.78
$3.35
Portata 52W:
Value
$2.78
$6.40

2 Seventy Bio Inc Stock (TSVT) Company Profile

Name
Nome
2 Seventy Bio Inc
Name
Telefono
339-499-9300
Name
Indirizzo
60 BINNEY STREET, CAMBRIDGE
Name
Dipendente
425
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-12
Name
Ultimi documenti SEC
Name
TSVT's Discussions on Twitter

Confronta TSVT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TSVT
2 Seventy Bio Inc
3.14 161.99M 44.12M -156.25M -154.61M -3.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-06 Downgrade Goldman Neutral → Sell
2024-01-31 Aggiornamento Leerink Partners Market Perform → Outperform
2024-01-31 Downgrade TD Cowen Outperform → Market Perform
2023-10-30 Downgrade Leerink Partners Outperform → Market Perform
2023-10-12 Iniziato Citigroup Buy
2023-09-13 Downgrade Goldman Buy → Neutral
2023-09-12 Downgrade Guggenheim Buy → Neutral
2023-07-28 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-10-31 Iniziato Guggenheim Buy
2022-05-02 Iniziato Goldman Buy
2022-02-10 Iniziato SVB Leerink Outperform
2022-01-06 Iniziato Cowen Outperform
2021-11-09 Iniziato Canaccord Genuity Buy
2021-11-08 Iniziato Morgan Stanley Overweight
2021-11-08 Iniziato Wedbush Outperform
Mostra tutto

2 Seventy Bio Inc Borsa (TSVT) Ultime notizie

pulisher
Dec 18, 2024

Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Dec 18, 2024
pulisher
Dec 16, 2024

Layoff Tracker: Editas Will Cut 60% of Staff - BioSpace

Dec 16, 2024
pulisher
Nov 15, 2024

Analysts Have Been Trimming Their 2seventy bio, Inc. (NASDAQ:TSVT) Price Target After Its Latest Report - Simply Wall St

Nov 15, 2024
pulisher
Nov 12, 2024

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress - Business Wire

Nov 12, 2024
pulisher
Nov 06, 2024

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results - GlobeNewswire

Nov 06, 2024
pulisher
Nov 04, 2024

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - Business Wire

Nov 04, 2024
pulisher
Oct 22, 2024

2seventy bio, Inc. (NASDAQ:TSVT) Shares Sold by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024
pulisher
Oct 17, 2024

BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS) - Yahoo Finance

Oct 17, 2024
pulisher
Oct 14, 2024

Dimensional Fund Advisors LP Sells 24,371 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Oct 14, 2024
pulisher
Oct 09, 2024

TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Oct 09, 2024
pulisher
Sep 27, 2024

BMS and 2seventy bio Axe Trial for Ide-Cel in Newly Diagnosed Multiple Myeloma - CGTLive™

Sep 27, 2024
pulisher
Sep 25, 2024

2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance - Business Wire

Sep 25, 2024
pulisher
Sep 24, 2024

Seven Eight Capital LP Makes New $197,000 Investment in Beyond, Inc. (NYSE:BYON) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Q&A: Athens legends Five Eight and the makers of their new documentary film, "Weirdo" - Online Athens

Sep 24, 2024
pulisher
Sep 22, 2024

Four killed, dozens injured in Alabama mass shooting - Daily Sun

Sep 22, 2024
pulisher
Sep 22, 2024

Seven Eight Capital LP Sells 536 Shares of Dell Technologies Inc. (NYSE:DELL) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Four dead, 17 others shot in Birmingham mass shooting - WJLA

Sep 22, 2024
pulisher
Sep 22, 2024

Five Below, Inc. (NASDAQ:FIVE) Stake Raised by Teca Partners LP - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Four killed, over 20 injured in Birmingham, Alabama shooting - Thaiger World

Sep 22, 2024
pulisher
Sep 22, 2024

At least four dead and dozens injured in shootout with multiple assailants in the United States - Top Buzz Times

Sep 22, 2024
pulisher
Sep 22, 2024

Four people dead and dozens injured in US mass shooting horror - Express

Sep 22, 2024
pulisher
Sep 21, 2024

Analyst bullish on Tectonic's TX45 ahead of full trial results presentation at AHA - Investing.com India

Sep 21, 2024
pulisher
Sep 19, 2024

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Hedge fund Two Sigma in settlement talks with US SEC, WSJ reports - XM

Sep 19, 2024
pulisher
Sep 19, 2024

US data: key federal and state updates (13 – 19 Sep) - Lexology

Sep 19, 2024
pulisher
Sep 10, 2024

The LYCRA Company Presents Seminars on Sustainable Elastane Solutions at the 63rd Dornbirn Global Fiber Congress - Via Ritzau

Sep 10, 2024
pulisher
Aug 18, 2024

Jessica Snow Sells 7,816 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) Stock - Defense World

Aug 18, 2024
pulisher
Aug 10, 2024

2seventy bio, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance

Aug 10, 2024
pulisher
Aug 07, 2024

2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress - Business Wire

Aug 07, 2024

2 Seventy Bio Inc Azioni (TSVT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):